Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
07/2004
07/08/2004CA2509882A1 Silyl ethers
07/07/2004EP1434579A1 Imidazole derivatives as antiinflammatory agents
07/07/2004EP1401431A4 Human growth hormone antagonists
07/07/2004CN1510031A Ester compounds of bezimidazole and their preparations and uses in preparation of medicinal compound
07/07/2004CN1156473C Hydrochloride of fused-heterocycle compound
07/06/2004US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/06/2004US6759425 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
07/06/2004US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease
07/06/2004US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
07/01/2004WO2004054984A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
07/01/2004WO2004054581A2 Cyclohexyl compounds as ccr5 antagonists
07/01/2004WO2004054515A2 Thrombopoietin mimetics
07/01/2004WO2004033426A3 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents
07/01/2004WO2004016086B1 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
07/01/2004WO2004005513A3 Methods for specifically inhibiting histone deacetylase-7 and 8
07/01/2004US20040127708 antiviral activities; aids treatment
07/01/2004US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease
07/01/2004US20040127504 Administering benzimidazole compound for therapy of sexual dysfunction in a mammal
07/01/2004US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome
07/01/2004DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
07/01/2004CA2508838A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
06/2004
06/30/2004EP1432700A1 Spiro-hydantoin compounds useful as anti-inflammatory agents
06/30/2004EP1432420A2 Benzimidazolidinone derivatives as muscarinic agents
06/30/2004EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer
06/30/2004EP1149072B1 Sulfonamide hydroxamates
06/30/2004CN1509275A Metalloproteinase inhibitors
06/30/2004CN1509274A Metallo proteinase inhibitors
06/30/2004CN1509273A Metalloproteinase inhibitors
06/30/2004CN1155558C N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
06/29/2004US6756384 Treatment of diseases and disorders related to the histamine h3 receptor.
06/29/2004CA2178604C Novel imidazole derivative and process for producing the same
06/24/2004WO2004052887A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
06/24/2004WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122125 Lactone compounds as novel photoinitiators
06/24/2004US20040122073 E.g., 1-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-2,5-dioxo-4-phenyl-3-(phenylmethyl)-4-imidazolidineacetamide; enzme enzyme inhibitors of the blood Factor VIIa complex; myocardial infarction; antiischemic agents; brain disorders ,
06/24/2004US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof
06/24/2004CA2508608A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
06/23/2004EP1430032A2 Substituted amides for the treatment of neurological disorders
06/23/2004EP1429765A2 Inhibitors of histone deacetylase
06/23/2004EP1429759A2 Compounds useful for treating hepatitus c virus
06/23/2004EP0980359B1 Benzimidazole derivative
06/23/2004CN1506355A Diphenyl benzimidazole compound containing sulfonyl group and its prepn process, medicinal composition and use
06/22/2004US6753347 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof
06/17/2004WO2004050681A2 Kinase modulators
06/17/2004WO2004050643A2 Non-nucleoside reverse transcriptase inhibitors
06/17/2004WO2004050637A2 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
06/17/2004WO2004050623A1 Methods for preparing phenylalkyne derivatives
06/17/2004WO2004050039A2 Spirocyclic ureas, compositions containing such compounds and methods of use
06/17/2004WO2004050035A2 Benzimidazoles and analogs thereof as antivirals
06/17/2004WO2004035534A3 Novel compounds having a dopaminergic and/or serotoninergic activity
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004WO2003105781A3 Ophthalmic compositions for treating ocular hypertension
06/17/2004US20040116710 N3 alkylated benzimidazole derivatives as MEK inhibitors
06/17/2004US20040116486 Metalloproteinase inhibitors
06/17/2004US20040116467 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
06/17/2004US20040116465 Novel compounds
06/17/2004US20040116443 Dopamine D4 ligands for the treatment of novelty-seeking disorders
06/17/2004US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators
06/17/2004US20040116387 thyroid receptor ligands, preferably antagonists for the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyrotoxicosis, subcllinical hyperthyrodism and liver diseases
06/17/2004CA2508581A1 Spirocyclic ureas, compositions containing such compounds and methods of use
06/17/2004CA2507875A1 Methods for preparing phenylalkyne derivatives
06/17/2004CA2506546A1 Kinase modulators
06/16/2004EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
06/16/2004CN1505615A Process for the preparation of phenylene-bis-benzimidazole-tetrasulfonic acid disodium salt
06/16/2004CN1505607A Peptide-deformylase inhibitors
06/15/2004US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
06/15/2004CA2192714C Quasiturbine (qurbine) zero vibration - continuous combustion rotary engine, compressor and pump
06/10/2004WO2004048342A1 Process for production of 1-[2-(benzimidazol-2-yl- thio)ethyl]piperazine or salts thereof
06/10/2004WO2004048317A1 Substituted amides active at the cannabinoid-1 receptor
06/10/2004WO2004047769A2 Benzimidazoles and analogs thereof as antibacterials
06/10/2004US20040110811 3-carbonyl- and sulfonyl derivatives: e.g., 1-Benzyl-3-naphthylcarbonyl-5,5-diphenylimidazolidine -2,4-dione; chymase and/or tryptase inhibition activity; especially treating chorioretinopathy, glaucoma, myopia or asthenopia.
06/10/2004US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione
06/10/2004US20040110808 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
06/10/2004US20040110753 Tyrosine derivatives
06/10/2004US20040110748 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
06/10/2004US20040110126 Hcv polymerase inhibitor assay
06/10/2004US20040107518 Mass coloration of substrates, as colorants in electrophotographic toners and developers, in powders and powder coating materials, in ink-jet inks and in cosmetic compositions; colorfastnessfast; heat and chemical resistance; azo-methine dyes
06/09/2004EP1100795B1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect
06/09/2004CN1503787A Novel compounds
06/09/2004CN1503784A 2-lminopyrrolidine derivatives
06/09/2004CN1503774A Carboxylic acid derivative and thereof
06/09/2004CN1152866C Benzimidazoles, production thereof and use thereof medicaments
06/08/2004CA2132528C Agent for use as an anti-irritant
06/03/2004WO2004046119A1 Substituted aralkyl derivatives
06/03/2004WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring
06/03/2004WO2004022060A8 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
06/03/2004WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106666 Hydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections
06/03/2004US20040106614 Useful for the treatment of psychiatric and neurological disorders, as well as other diseases involving cannabinoid-CB1 neurotransmission
06/03/2004US20040106606 Dihydropyrones with tethered heterocycles
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004CA2506112A1 Substituted aralkyl derivatives
06/03/2004CA2506010A1 A method for deuteration of a heterocyclic ring
06/02/2004EP0769966B1 Biotin compounds for targetting tumors and sites of infection
06/02/2004CN1152020C Benzimidazolrone and analogues, and uses as progesterone ligand thereof
05/2004
05/27/2004WO2004043913A2 Hetero-substituted benzimidazole compounds and antiviral uses thereof
05/27/2004US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease
05/27/2004US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 154